Key Statistics
Market Cap$26.54M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.26
52W High$6.26
52W Low$0.64
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week-1.29%
3 Month-19.31%
1 Year+157.38%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$4.31M
Liabilities$313,858
Net Income$5.09M loss
About
Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets related to serious common diseases and designs novel compounds to attack those targets. The company is headquartered in East Setauket, New York.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze LIXT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
